Creso Pharma Ltd.(ASX: CPH) is a leader in cannabidiol (CBD) innovation and it is involved in the operations of developing medical cannabis products. Creso’s products have wide-ranging applications in both human and animal health. In July 2017, the Company successfully expanded its business into the Canadian market through the acquisition of Mernova Medicinal Inc, for a total consideration of A$10.2 million.
On 17 October 2018, Creso Pharma Ltd (ASX: CPH) made an announcement on ASX in which the company welcomes the decision of Canada of becoming the second country in the world and the first G7 nation to legalize the recreational use of cannabis nationwide. According to the Canadian Prime Minister Justin Trudeau, this bill will help in bringing regulation in the black market and taxation system.
Creso is the only company listed on the ASX that owns